These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
46. [Urographic abnormalities caused by adverse reactions to the contrast medium (author's transl)]. Tsubogo Y; Tonariya Y; Fujioka M Nihon Igaku Hoshasen Gakkai Zasshi; 1978 Oct; 38(10):931-5. PubMed ID: 733465 [No Abstract] [Full Text] [Related]
47. [Angiography with iodamide--clinical test of a triiodide contrast medium]. Kaude J Lakartidningen; 1971 Oct; 68():Suppl 4:42-8. PubMed ID: 4949294 [No Abstract] [Full Text] [Related]
48. [Application of higher doses of contrast medium in i.v. urography (author's transl)]. Bardach G; Schratter H Wien Klin Wochenschr; 1974 Nov; 86(21):651-4. PubMed ID: 4428777 [No Abstract] [Full Text] [Related]
49. [Risk of application of contrast medium in computed tomography (author's transl)]. Wende S; Speck U Radiologe; 1981 Jun; 21(6):268-73. PubMed ID: 7022551 [TBL] [Abstract][Full Text] [Related]
50. [Hemodynamic effects in man of an injection of a new contrast medium for cholangiography]. Ambrosioni E; Catizone L; Chiarini C; Costa V; Perri G G Clin Med; 1972 Mar; 53(3):132-41. PubMed ID: 4567883 [No Abstract] [Full Text] [Related]
51. Effect of iohexol, metrizamide and ioxaglate on the blood-brain barrier. Aulie A Acta Radiol Suppl; 1980; 362():13-6. PubMed ID: 6267885 [TBL] [Abstract][Full Text] [Related]
52. Iodinated contrast agents as "radiosensitizers". Dawson P; Penhaligon M; Smith E; Saunders J Br J Radiol; 1987 Feb; 60(710):201-3. PubMed ID: 3815019 [No Abstract] [Full Text] [Related]
53. The action of iohexol on clotting, fibrinolysis, complement and kallikrein system. Schulze B; Beyer HK; Barth V; Tremmel K; Borst U Fortschr Geb Rontgenstrahlen Nuklearmed Erganzungsbd; 1983; 118():18-23. PubMed ID: 6139074 [No Abstract] [Full Text] [Related]
54. [A contribution to the rate of side-effects of hepatotropic contrast media. A clinical comparative study of iodoxamate (Endomirabil) and ioglycamid (Bilivistan) (author's transl)]. Kölling K; Hoenle R; Korsten FW Radiologe; 1977 Feb; 17(2):70-3. PubMed ID: 322198 [TBL] [Abstract][Full Text] [Related]
55. Comparative radiological studies of Uromiro and Urografin as contrast media for excretion urography. Adamali N; Raja R East Afr Med J; 1979 Nov; 56(11):593-6. PubMed ID: 520238 [No Abstract] [Full Text] [Related]
56. [Action of contrast media solutions on cardiac hemodynamic parameters during the coronary angiography in the pig (author's transl)]. Lautrou J; Bergin M; Cardinal A Ann Radiol (Paris); 1978; 21(4-5):261-5. PubMed ID: 718078 [No Abstract] [Full Text] [Related]
57. Pain in peripheral arteriography-a comparison of a low osmolality contrast medium with a conventional compound. Tillmann U; Adler R; Fuchs WA Br J Radiol; 1979 Feb; 52(614):102-4. PubMed ID: 371733 [TBL] [Abstract][Full Text] [Related]
58. [Clinical experiences with the new contrast medium iodamide 420 (author's transl)]. Fráter LL; Száva J; Gaál T; Kertész E Rontgenblatter; 1978 Jan; 31(1):38-45. PubMed ID: 622530 [TBL] [Abstract][Full Text] [Related]
59. Hemorrheologic effects of iotrolan after intra-arterial injection in rabbits: comparison with other types of contrast media. Nauert C; Langer M; Mützel W Fortschr Geb Rontgenstrahlen Nuklearmed Erganzungsbd; 1989; 128():40-5. PubMed ID: 2568806 [TBL] [Abstract][Full Text] [Related]
60. Chemistry, physicochemistry and pharmacology of known and new contrast media for angiography, urography and CT enhancement. Speck U; Mützel W; Weinmann HJ Fortschr Geb Rontgenstrahlen Nuklearmed Erganzungsbd; 1983; 118():2-10. PubMed ID: 6139075 [No Abstract] [Full Text] [Related] [Previous] [Next] [New Search]